Pfizer Says Vaccine Safely Produces Antibodies in Younger Kids

The video discusses the release of initial data on COVID-19 vaccines for children, emphasizing the importance of vaccinating children to prevent transmission. It covers the need to determine the right dosage and monitor side effects, which may differ from adults. The process for emergency approval is outlined, highlighting the potential challenges in supply and prioritization, especially with the concurrent demand for booster shots.

What factors are considered when determining the right dose of the vaccine for children?

What is the expected time frame for emergency approval of the vaccine for children aged 5 to 11?